Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We cloned the Aspergillus oryzae
tannase
gene using three oligodeoxyribonucleotide (oligo) probes synthesized according to the
tannase
N-terminal and an internal amino acid (aa) sequence. The nucleotide (nt) sequence of the
tannase
gene was determined and compared with that of a
tannase
DNA complementary to RNA (cDNA) by means of
reverse transcriptase
PCR. The results indicated that there was no intron in the
tannase
gene and that it coded for 588 aa with a molecular weight of about 64,000. The
tannase
low-producing strain A. oryzae AO1 was transformed with the plasmid pT1 which contained the
tannase
gene, and
tannase
activities of the transformants increased in proportion to the number of copies. Tannase consisted of two kinds of subunits, linked by a disulfide bond(s) with molecular weights of about 30,000 and 33,000, respectively. We purified these subunits and determined their N-terminal aa sequences. The large and small subunits of
tannase
were encoded by the first and second halves, respectively. Judging from the above results, the
tannase
gene product is translated as a single polypeptide that is cleaved by post-translational modification into two
tannase
subunits linked by a disulfide bond(s). We concluded that native
tannase
consisted of four pairs of the two subunits, forming a hetero-octamer with a molecular weight of about 300,000.
...
PMID:Cloning and sequencing of the gene encoding tannase and a structural study of the tannase subunit from Aspergillus oryzae. 891 2